Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2003-09-29
2008-10-21
Nickol, Gary (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S198100, C435S335000, C435S007100, C530S387100, C530S387900
Reexamination Certificate
active
07438913
ABSTRACT:
Polypeptides capable of binding human IL-13 and/or of binding human IL-4 in the presence of IL-4 Rα can be used in medicine, in diagnosis and in screening for agonists/antagonist of IL-13/IL-4. One such polypeptide is shown inFIG. 1.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5453491 (1995-09-01), Takatsu et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 6911530 (2005-06-01), Willson et al.
patent: WO 97/20926 (1997-06-01), None
patent: WO 97/31946 (1997-09-01), None
Caput et al. “Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain” J. Biol. Chem. 271:16921-16926 (1996).
Minty et al. “Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses” Nature 362:248-250 (1993).
Aman et al. “cDNA Cloning and characterization of the human interleukin 13 receptor α chain” J. Biol. Chem. 271:29265-29270 (1996).
Hilton et al. “Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor” Proc. Natl. Acad. Sci. USA 93:497-501 (1996).
Callard et al. “IL-4 and IL-13 receptors: Are they one and the same?” Immunology Today 17:108-110 (1996).
George et al. “Current methods in sequence comparison and analysis, selected methods and applications” (Schlesinger, ed.) Alan R. Liss, pp. 124-129 (1998).
Ngo et al. “Computational complexity, protein structure prediction, and the Levinthal paradox—The protein folding problem and tertiary structure prediction” (Merz & LeGrand, eds.) Birkhäuser Boston, pp. 491-495 (1995).
Bowie et al. “Deciphering the message in protein sequences: Tolerance to amino acid substitutions” Science 247:1306-1310 (1990).
Bonnefoy Jean-Yves
Gauchat Jean-François
Basi Nirmal S
Dermott Jonathan M.
Gimmi Edward R.
Nickol Gary
SmithKline Beecham Corporation
LandOfFree
Substances and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substances and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substances and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4014752